THOMAS DOLCA (Chief Medical Officer) sold 89.1% of their position (15K shares) of PRINCIPIA BIOPHARMA INC. on the open market
Open‑market sale worth $1.20M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/17/2020ACC: 0001209191-20-043008
Officer· Chief Medical Officer
Since Feb 2019
-15K
Net shares
Net seller
$1.20M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
15K acquired · 30K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+15K
Price / share
$23.77
Trade value
$356.55K
% of position
821.5%
7/15/2020
1.83K→16.83K
Common Stock
Direct
Shares
−15K
Price / share
$80.07
Trade value
$1.20M
% of position
89.1%
7/15/2020
16.83K→1.83K
Total
Net shares
+0.00
Net value
-$844.52K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/15/2020 | M · Option Exercise | +15K | $23.77 | $356.55K | 821.5% | 1.83K | 16.83K |
| Common Stock Direct | 7/15/2020 | S · Sale | −15K | $80.07 | $1.20M | 89.1% | 16.83K | 1.83K |
| Total | +0.00 | -$844.52K | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
15K shares
Shares
−15K
Strike price
23.77
Held after
183.06K
Exercisable
—
7/15/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock15K shares | 7/15/2020 | M · Option Exercise | −15K | 23.77 | — | 183.06K |